Skip to main content

Table 1 Patients’ demographic, clinical characteristics, and outcomes

From: Cesarean scar pregnancy treatment: a case series

Characteristics

Case 1

Case 2

Case 3

Case 4

Age (years)

32

34

29

33

Previous cesarean section

Yes

Yes

Yes

Yes

History of curettage

No

No

Yes

No

Gestational age

6 weeks

6 weeks

6 weeks

5 weeks and 5 days

Size of the sac (mm)

10

14

14

11

Initial β-hCG (IU/L)

7000

19,000

11,000

3546

Primary treatment

Systemic MTX

Systemic MTX

Systemic MTX

Systemic MTX

β-hCG level 4 days after treatment (IU/L)

4900

29,000

10,000

4800

Second treatment

No

Yes

No

Yes

β-hCG level 4 days after

second treatment (IU/L)

32,000

6500

Time to reach negative β-hCG

4 weeks

9 weeks

6 weeks

5 weeks

  1. MTX Methotrexate, β-hCG Beta-human chorionic gonadotropin